In today's medical environment, personalised medicine is a significant movement. It tries to shift the focus away from the old practise of prescribing standard doses of standard medications to every patient for a condition and toward targeting the specific drug and dose required based on the patient's physiology. Nanotechnology and personalised medicine are two of the newest areas of biomedical research, as well as two of the most promising technologies for enhancing health care and outcomes. In addition, they are fast convergent in a variety of current and future therapeutic applications. Nanotechnology has a number of benefits for personalised medicine applications, including a size that matches the scale of personalised medicine's molecular substrates, increased sensitivity in detecting and binding with target molecules, and flexibility in the design and features of diagnostics and therapeutics at the nano scale.
Title : The role of ATP as a Hydrotrope in health and disease
Jack V Greiner, Harvard Medical School, United States
Title : Precision treatment of alzheimer's
Boris Tankhilevich, Magtera, Inc., United States
Title : Modeling competition between subpopulations with variable DNA content in resource limited microenvironments
Noemi Andor, H. Lee Moffitt Cancer Center & Research Institute, United States
Title : Progesterone receptor pathways in preterm birth
Beverlee Wood, Case Western Reserve University, United States
Title : The use of anti seizure medication therapeutic blood level determination to personalise the treatment of epileptic seizures especially in patients attending the accident and emergency department
Roy Gary Beran, University of New South Wales, Australia
Title : Monitoring folds localization in ultra-thin transition metal dichalcogenides using Optical Harmonic Generation
Ahmed Raza Khan, Australian National University, Australia